OverviewSuggest Edit

DNAnexus is a company that develops a biomedical informatics and data management platform that allows analyzing DNA-sequencing data. Its platform helps researchers to accelerate their genomics programs, as well as allows academic medical researchers to visualize and analyze big data system for DNA from a single, unified system.
HQMountain View, CA, US
Employee Ratings4.6
Overall CultureD+

Latest Updates

Employees (est.) (May 2021)162(+2%)
Job Openings32

Key People/Management at DNAnexus

Richard Daly

Richard Daly

George Asimenos

George Asimenos

Tim OBrien

Tim OBrien

Vice President of Sales
Omar Serang

Omar Serang

Chief Cloud Officer
Show more

DNAnexus Office Locations

DNAnexus has offices in Mountain View, Boston, San Francisco and Washington
Mountain View, CA, US (HQ)
1975 W El Camino Real
Boston, MA, US
Boston, MA, USA
San Francisco, CA, US
703 Market St #2100, San Francisco
Washington, DC, US
Washington, DC, USA
Show all (4)

DNAnexus Financials and Metrics

Summary Metrics

Founding Date


DNAnexus total Funding

$272.6 m

DNAnexus latest funding size

$100 m

Time since last funding

a year ago

DNAnexus investors

DNAnexus's latest funding round in June 2020 was reported to be $100 m. In total, DNAnexus has raised $272.6 m
Show all financial metrics

DNAnexus Online and Social Media Presence

Embed Graph

DNAnexus Company Culture

  • Overall Culture



  • CEO Rating



  • Compensation



Learn more on Comparably

DNAnexus News and Updates

DNAnexus raises $100M for a cloud-based analytics platform aimed at genomics and other clinical big data

DNAnexus, which provides a cloud platform for governments, universities, doctors, and pharmaceutical companies to tap into DNA and other clinical datasets and collaborate on scientific research projects, is today announcing a big step ahead in its efforts to grow its reach and purpose. The 10 year-o…

Sutter, UPMC and DNAnexus forge precision medicine partnership

The teams will collect, process and analyze EHR data of up to 3,000 patients to create personalized care plans for people with MS.

DNAnexus Blogs

MIODx: A Breakthrough Leader in the precisionFDA COVID-19 Precision Immunology App-a-thon

The results are in for precisionFDA’s COVID-19 Precision Immunology App-a-thon, and we are thrilled to announce our partner, MIODx, demonstrated strong leadership in their field by taking home medals in multiple categories!   Motivation Behind the COVID-19 Precision Immunology App-a-thon  Despite th…

Responding to the Evolving World of COVID-19 Through Global Collaboration

Will the next wave of COVID-19 surveillance come via wastewater? What challenges lay ahead as we try to detect variants in a constantly evolving viral population, and adjust our therapeutics accordingly? How could bioinformatics help? These were some of the questions raised during a recent roundtabl…

Seqera Labs and DNAnexus Announce Availability of Nextflow App on DNAnexus

If Linux is the lingua franca of data science, then Seqera Lab’s open-source workflow orchestrator, Nextflow, is the ideal tool to simplify writing and deploying of data-intensive pipelines. And we are excited to now be able to offer beta availability of Nextflow as a third-party app on the DNAnexus…

DNAnexus Platform and Product Updates: 2020 in Review

Everyone is happy to see 2020 receding in the rearview mirror. But while last year was difficult in so many respects, it was productive for the DNAnexus Product team. Here’s a list of some of the features and enhancements we released in 2020: Improved Cohort Building and Analysis Experience We made …

Looking Beyond Causative Variants to Help Rare Disease Researchers Identify Elusive Treatment Options

Ever heard of schwannomatosis? How about neurofibromatosis? They are rare diseases that are not as rare as you might think, affecting around one in every 3,000 people worldwide.  At DNAnexus, we are proud to help enable research into these and other ‘rare’ genetic conditions.  One research partner i…

New UK Biobank Exome Pipeline: A 1-Button Read-Mapping Protocol for Public Sequencing Datasets

Public genomic resources such as UK Biobank are invaluable to researchers around the world. But the size and complexity of these datasets — which often measure in hundreds of thousands of samples and petabytes of data — present a barrier to many users, even if the data are openly accessible to bona …
Show more

DNAnexus Frequently Asked Questions

  • When was DNAnexus founded?

    DNAnexus was founded in 2009.

  • Who are DNAnexus key executives?

    DNAnexus's key executives are Richard Daly, George Asimenos and Tim OBrien.

  • How many employees does DNAnexus have?

    DNAnexus has 162 employees.

  • Who are DNAnexus competitors?

    Competitors of DNAnexus include HistoGeneX, Singular Genomics and Oxford Gene Technology.

  • Where is DNAnexus headquarters?

    DNAnexus headquarters is located at 1975 W El Camino Real, Mountain View.

  • Where are DNAnexus offices?

    DNAnexus has offices in Mountain View, Boston, San Francisco and Washington.

  • How many offices does DNAnexus have?

    DNAnexus has 4 offices.